The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
Volume 348:2055-2056 May 22, 2003 Number 21
NextNext

The National Emphysema Treatment Trial — How Strong Is the Evidence?
James H. Ware, Ph.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by National Emphysema Treatment Trial Research Group
-PubMed Citation
The National Emphysema Treatment Trial (NETT), reported in this issue of the Journal (pages 2059–2073) raises interesting questions about the interpretation of secondary analyses of data collected in clinical trials. After exclusion of 140 patients with a high risk of death from surgery according to an interim analysis,1 the 538 patients who were randomly assigned to surgery were more likely than the 540 assigned to medical therapy to have improvements in exercise capacity and quality of life, but there was no reduction in mortality during an average of 29 months of follow-up.

In the secondary analyses, however, the effects of . . . [Full Text of this Article]


Source Information

This article was published at www.nejm.org on May 20, 2003.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.